Horsemen Contribute $170,000 to Improve Equine Drug Testing: THA 4/9/19

Press Release: The Thoroughbred Horsemen’s Association, led by a $25,000 donation from the New York THA, will contribute a total of $50,000 to fund research to develop an inexpensive test for the detection of potential blood-doping agents such as erythropoietin. The two-year study, an initiative of the Racing Medication and Testing Consortium, will be conducted

Test sought to identify new horse blood-doping strategy: Horsetalk 3/11/19

Press Release: Anecdotal reports suggest that some racehorses are being given micro-doses of recombinant human erythropoietin to improve performance, according to the equine medical director for the Kentucky Horse Racing Commission. The micro-dosing regime is designed to avoid detection of the drug, which stimulates the production of oxygen-carrying red blood cells. Abuse of the substance,

KHRC Approves Study to Develop EPO Micro-Dosing Test: Bloodhorse 2/20/19

By: Frank Angst The Kentucky Horse Racing Commission has approved $147,000 from the Kentucky Equine Drug Research Council fund for a two-year study that aims to develop an affordable test to detect horses that have been given small levels—microdoses—of erythropoietin. Heather Knych, of the Ken L. Maddy Equine Analytical Chemistry Laboratory at the University of

RCI Has New Take on Out-of-Competition Tests: The Blood-Horse 2/6/15

By Tom LaMarra The umbrella group for regulators in North America is examining a new approach to out-of-competition testing that would not only target blood-doping and gene-doping, but also help identify horses at risk of catastrophic injury. Out-of-competition testing, on the books in eight states, has different rules depending on the jurisdiction but was enacted

Privacy Policy Ok